NVNO

USD

enVVeno Medical Corporation Common Stock

$2.735-0.031 (-1.121%)

السعر في الوقت الحقيقي

Healthcare

الأجهزة الطبية

الولايات المتحدة

مخطط الأسعار

المقاييس الرئيسية

مقاييس السوق

أساسيات الشركة

إحصاءات التداول

مقاييس السوق

الافتتاح

$2.766

الأعلى

$2.766

الأدنى

$2.660

الحجم

0.00M

أساسيات الشركة

القيمة السوقية

48.0M

الصناعة

الأجهزة الطبية

البلد

United States

إحصاءات التداول

متوسط الحجم

0.09M

البورصة

NCM

العملة

USD

نطاق 52 أسبوعاً

الأدنى $2.028الحالي $2.735الأعلى $6.48

أخبار ذات صلة

١٩ فبراير ٢٠٢٥ · ٠١:٥٥ م

AccessWire

Virtual Investor "Top 5 for '25" Conference Hosted by JTC Now Available On-Demand

- Access video webcasts from the first wave of participating companies hereFRENCHTOWN, NJ / ACCESS Newswire / February 19, 2025 / JTC Team , a fully integrated corporate communications and investor

عرض المزيد

Virtual Investor "Top 5 for '25" Conference Hosted by JTC Now Available On-Demand

١٩ فبراير ٢٠٢٥ · ٠١:٤٥ م

AccessWire

One-Year Data from the VenoValve(R) U.S. Pivotal Trial Highlighting Impact on Patients' Quality of Life (QOL) to be Presented Today at the 37th Annual Meeting of the American Venous Forum

One-year follow-up data demonstrates sustained improvements across venous specific quality-of-life indicators.PMA application for the VenoValve submitted in November 2024, with an FDA decision expected in the

عرض المزيد

One-Year Data from the VenoValve(R) U.S. Pivotal Trial Highlighting Impact on Patients' Quality of Life (QOL) to be Presented Today at the 37th Annual Meeting of the American Venous Forum

٧ فبراير ٢٠٢٥ · ٠٢:٠٠ م

AccessWire

Interim Two-Year Follow-Up Data from the VenoValve(R) U.S. Pivotal Trial to be Presented Today at the VESS 2025 Annual Winter Meeting

Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.78% of subjects maintained a clinically meaningful

عرض المزيد